Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for parkinson's disease

Frontiers in Aging Neuroscience

Volumn 7, Issue MAR, 2015, Pages

  Esteves, Marta ^a   Cristóvão, Ana C ^a   Saraiva, Tatiana ^a   Rocha, Sandra M ^a   Baltazar, Graça ^a   Ferreira, Lino ^b,c   Bernardino, Liliana ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Biocant Center of Innovation in Biotechnology   (Portugal)

Author keywords

Dopaminergic neurons; Nanoparticles; Neuroprotection; Parkinson's disease; Retinoic acid

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DEXTRAN SULFATE; MESSENGER RNA; NANOPARTICLE; NUCLEAR RECEPTOR RELATED FACTOR 1; POLYETHYLENEIMINE; POLYMER; RETINOIC ACID; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; INNERVATION; INTRACELLULAR TRANSPORT; MOUSE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; YOUNG ADULT; ZETA POTENTIAL;

EID: 84926392573     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00020     Document Type: Article

References (41)

1. Bastien, J., and Rochette-Egly, C. (2004). Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328, 1-16. doi: 10.1016/j.gene.2003.12.005
2. Blasko, I., Stampfer-Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., and Grubeck-Loebenstein, B. (2004). How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 3, 169-176. doi: 10.1111/j.1474-9728.2004.00101.x
3. Buervenich, S., Carmine, A., Galter, D., Shahabi, H. N., Johnels, B., Holmberg, B., et al. (2005). A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch. Neurol. 62, 74-78. doi: 10.1001/archneur.62.1.74
4. Casey, J. R., Grinstein, S., and Orlowski, J. (2010). Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 11, 50-61. doi: 10.1038/nrm2820
5. Castro, G. A., Orefice, R. L., Vilela, J. M., Andrade, M. S., and Ferreira, L. A. (2007). Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J. Microencapsul. 24, 395-407. doi: 10.1080/02652040701288519
6. Chu, Y., Kompoliti, K., Cochran, E. J., Mufson, E. J., and Kordower, J. H. (2002). Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J. Comp. Neurol. 450, 203-214. doi: 10.1002/cne.10261
7. Decressac, M., Pain, S., Chabeauti, P. Y., Frangeul, L., Thiriet, N., Herzog, H., et al. (2012). Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiol. Aging 33, 2125-2137. doi: 10.1016/j.neurobiolaging.2011.06.018
8. Galter, D., Buervenich, S., Carmine, A., Anvret, M., and Olson, L. (2003). ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol. Dis. 14, 637-647. doi: 10.1016/j.nbd.2003.09.001
9. Garbayo, E., Montero-Menei, C. N., Ansorena, E., Lanciego, J. L., Aymerich, M. S., and Blanco-Prieto, M. J. (2009). Effective GDNF brain delivery using microspheres-a promising strategy for Parkinson's disease. J. Control. Release 135, 119-126. doi: 10.1016/j.jconrel.2008.12.010
10. Gibrat, C., Saint-Pierre, M., Bousquet, M., Levesque, D., Rouillard, C., and Cicchetti, F. (2009). Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J. Neurochem. 109, 1469-1482. doi: 10.1111/j.1471-4159.2009.06072.x
11. Grunblatt, E., Zehetmayer, S., Jacob, C. P., Muller, T., Jost, W. H., and Riederer, P. (2010). Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease. J. Neural Transm. 117, 1387-1393. doi: 10.1007/s00702-010-0509-1
12. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatr. 79, 368-376. doi: 10.1136/jnnp.2007.131045
13. Jankovic, J., Chen, S., and Le, W. D. (2005). The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog. Neurobiol. 77, 128-138. doi: 10.1016/j.pneurobio.2005.09.001
14. Jarvis, M. F., and Wagner, G. C. (1985). Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Neuropharmacology 24, 581-583. doi: 10.1016/0028-3908(85)90068-1
15. Kastner, P., Mark, M., Ghyselinck, N., Krezel, W., Dupe, V., Grondona, J. M., et al. (1997). Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124, 313-326.
16. Katsuki, H., Kurimoto, E., Takemori, S., Kurauchi, Y., Hisatsune, A., Isohama, Y., et al. (2009). Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling. J. Neurochem. 110, 707-718. doi: 10.1111/j.1471-4159.2009.06171.x
17. Kong, X. Y., Cai, Z., Pan, L., Zhang, L., Shu, J., Dong, Y. L., et al. (2008). Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice. Brain Res. 1205, 108-115. doi: 10.1016/j.brainres.2008.02.040
18. Liu, H., Wei, L., Tao, Q., Deng, H., Ming, M., Xu, P., et al. (2012). Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson's disease. Eur. J. Neurol. 19, 870-875. doi: 10.1111/j.1468-1331.2011.03644.x
19. Luk, K. C., Rymar, V. V., Van Den Munckhof, P., Nicolau, S., Steriade, C., Bifsha, P., et al. (2013). The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress. J. Neurochem. 125, 932-943. doi: 10.1111/jnc.12160
20. Maden, M. (2007). Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 8, 755-765. doi: 10.1038/nrn2212
21. Maia, J., Santos, T., Aday, S., Agasse, F., Cortes, L., Malva, J. O., et al. (2011). Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles. ACS Nano 5, 97-106. doi: 10.1021/nn101724r
22. McCaffery, P., and Drager, U. C. (1994). High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. U.S.A. 91, 7772-7776. doi: 10.1073/pnas.91.16.7772
23. Narvekar, M., Xue, H. Y., and Wong, H. L. (2012). A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). Int. J. Pharm. 436, 721-731. doi: 10.1016/j.ijpharm.2012.07.042
24. Paxinos, G., and Franklin, K. B. J. (2001). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
25. Peng, J., and Andersen, J. K. (2011). Mutant alpha-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Aging Cell 10, 255-262. doi: 10.1111/j.1474-9726.2010.00656.x
26. Penniston, K. L., and Tanumihardjo, S. A. (2006). The acute and chronic toxic effects of vitamin A. Am. J. Clin. Nutr. 83, 191-201.
27. Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. doi: 10.1093/nar/29.9.e45
28. Puttagunta, R., and Di Giovanni, S. (2011). Retinoic acid signaling in axonal regeneration. Front. Mol. Neurosci. 4:59. doi: 10.3389/fnmol.2011.00059
29. Regnier-Delplace, C., Thillaye Du Boullay, O., Siepmann, F., Martin-Vaca, B., Degrave, N., Demonchaux, P., et al. (2013). PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine. Int. J. Pharm. 443, 68-79. doi: 10.1016/j.ijpharm.2013.01.008
30. Rojas, P., Ruiz-Sanchez, E., Rojas, C., and Ogren, S. O. (2012). Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neuroscience 223, 246-257. doi: 10.1016/j.neuroscience.2012.08.004
31. Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., et al. (2009). A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59. doi: 10.1016/j.cell.2009.01.038
32. Santos, T., Ferreira, R., Maia, J., Agasse, F., Xapelli, S., Cortes, L., et al. (2012). Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain. ACS Nano 6, 10463-10474. doi: 10.1021/nn304541h
33. Serra, P. A., Sciola, L., Delogu, M. R., Spano, A., Monaco, G., Miele, E., et al. (2002). The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes. J. Biol. Chem. 277, 34451-34461. doi: 10.1074/jbc. M202099200
34. Smidt, M. P., Van Schaick, H. S., Lanctot, C., Tremblay, J. J., Cox, J. J., Van Der Kleij, A. A., et al. (1997). A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 94, 13305-13310. doi: 10.1073/pnas.94.24.13305
35. Smits, S. M., Ponnio, T., Conneely, O. M., Burbach, J. P., and Smidt, M. P. (2003). Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 18, 1731-1738. doi: 10.1046/j.1460-9568.2003.02885.x
36. Suzuki, H., Ono, K., and Sawada, M. (2014). Protective effect of INI-0602, a gap junction inhibitor, on dopaminergic neurodegeneration of mice with unilateral 6-hydroxydopamine injection. J. Neural. Transm. 121, 1349-1355. doi: 10.1007/s00702-014-1209-z
37. Szuts, E. Z., and Harosi, F. I. (1991). Solubility of retinoids in water. Arch. Biochem. Biophys. 287, 297-304. doi: 10.1016/0003-9861(91)90482-X
38. Thang, S. H., Kobayashi, M., and Matsuoka, I. (2000). Regulation of glial cell line-derived neurotrophic factor responsiveness in developing rat sympathetic neurons by retinoic acid and bone morphogenetic protein-2. J. Neurosci. 20, 2917-2925.
39. Xu, J., and Drew, P. D. (2006). 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 171, 135-144. doi: 10.1016/j.jneuroim.2005.10.004
40. Yin, L. H., Shen, H., Diaz-Ruiz, O., Backman, C. M., Bae, E., Yu, S. J., et al. (2012). Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease. BMC Neurosci. 13:120. doi: 10.1186/1471-2202-13-120
41. Zetterstrom, R. H., Williams, R., Perlmann, T., and Olson, L. (1996). Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res. Mol. Brain Res. 41, 111-120. doi: 10.1016/0169-328X(96)00074-5